Intellia Therapeutics Inc buy BenchmarkLong70
Start price
29.10.24
/
50%
€15.30
Target price
29.11.24
-
Performance (%)
-2.62%
End price
30.11.24
€14.90
Summary
This prediction ended on 30.11.24 with a price of €14.90. With a performance of -2.62%, the BUY prediction by BenchmarkLong70 finished with a loss. BenchmarkLong70 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Intellia Therapeutics Inc | -4.970% | -4.970% | -15.436% |
| iShares Core DAX® | 1.717% | 3.368% | 5.887% |
| iShares Nasdaq 100 | -4.565% | -4.238% | 21.386% |
| iShares Nikkei 225® | -7.120% | -11.869% | 42.357% |
| iShares S&P 500 | -0.894% | 1.687% | 19.495% |
Comments by BenchmarkLong70 for this prediction
In the thread Trading Intellia Therapeutics Inc
Die von BenchmarkLong70 gewählte maximale Laufzeit wurde überschritten